Skip to main navigation Skip to search Skip to main content

Cardiac toxicity in a pilot study of duvelisib and ibrutinib combination therapy for chronic lymphocytic leukaemia

  • Shira R. Paul
  • , Douglas R. Rosing
  • , Mark C. Haigney
  • , Cody J. Peer
  • , William D. Figg
  • , Adrian Wiestner
  • , Clare Sun*
  • *Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

2 Scopus citations
Original languageEnglish
Pages (from-to)261-263
Number of pages3
JournalBritish Journal of Haematology
Volume200
Issue number2
DOIs
StatePublished - Jan 2023

Keywords

  • B lymphocytes
  • Bruton tyrosine kinase inhibitor
  • CLL
  • cardiology
  • non-Hodgkin lymphoma

Fingerprint

Dive into the research topics of 'Cardiac toxicity in a pilot study of duvelisib and ibrutinib combination therapy for chronic lymphocytic leukaemia'. Together they form a unique fingerprint.

Cite this